These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18339856)

  • 1. 14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling.
    Danes CG; Wyszomierski SL; Lu J; Neal CL; Yang W; Yu D
    Cancer Res; 2008 Mar; 68(6):1760-7. PubMed ID: 18339856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
    Swaroop M; Sun Y
    Anticancer Res; 2003; 23(4):3167-74. PubMed ID: 12926050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells.
    Brunquell C; Biliran H; Jennings S; Ireland SK; Chen R; Ruoslahti E
    Mol Cancer Res; 2012 Nov; 10(11):1482-95. PubMed ID: 22952044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of murine double minute 2 by Akt in mammary epithelium delays mammary involution and accelerates mammary tumorigenesis.
    Cheng X; Xia W; Yang JY; Hsu JL; Lang JY; Chou CK; Du Y; Sun HL; Wyszomierski SL; Mills GB; Muller WJ; Yu D; Hung MC
    Cancer Res; 2010 Oct; 70(19):7684-9. PubMed ID: 20841468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways.
    Li H; Wang Z; Jiang M; Fang RP; Shi H; Shen Y; Cai XL; Liu Q; Ye K; Fan SJ; Zhang WY; Ye LH
    Acta Pharmacol Sin; 2018 Nov; 39(11):1787-1796. PubMed ID: 30181579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways.
    Yang L; Hou Y; Yuan J; Tang S; Zhang H; Zhu Q; Du YE; Zhou M; Wen S; Xu L; Tang X; Cui X; Liu M
    Oncotarget; 2015 Sep; 6(28):25755-69. PubMed ID: 26342198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
    Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tightly controlled MRTF-A activity regulates epithelial differentiation during formation of mammary acini.
    Seifert A; Posern G
    Breast Cancer Res; 2017 Jun; 19(1):68. PubMed ID: 28592291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
    Liu K; Xue B; Bai G; Zhang W
    Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus decreases p53 protein to prolong survival of airway epithelial cells.
    Groskreutz DJ; Monick MM; Yarovinsky TO; Powers LS; Quelle DE; Varga SM; Look DC; Hunninghake GW
    J Immunol; 2007 Sep; 179(5):2741-7. PubMed ID: 17709487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer.
    Chen M; Zhang H; Zhang G; Zhong A; Ma Q; Kai J; Tong Y; Xie S; Wang Y; Zheng H; Guo L; Lu R
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):74-82. PubMed ID: 30454896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics in the p53-Mdm2 ubiquitination pathway.
    Brooks CL; Gu W
    Cell Cycle; 2004 Jul; 3(7):895-9. PubMed ID: 15254415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol inhibits MDM2 and induces apoptosis in breast cancer cells through a p53-independent pathway.
    Xu J; Han M; Shen J; Guan Q; Bai Z; Lang B; Zhang H; Li Z; Zuo D; Zhang W; Wu Y
    Cancer Lett; 2016 Dec; 383(1):9-17. PubMed ID: 27693458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional cooperation of RKTG with p53 in tumorigenesis and epithelial-mesenchymal transition.
    Jiang Y; Xie X; Li Z; Wang Z; Zhang Y; Ling ZQ; Pan Y; Wang Z; Chen Y
    Cancer Res; 2011 Apr; 71(8):2959-68. PubMed ID: 21385899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between STAT5 activation and PI3K/AKT functions in normal and transformed mammary epithelial cells.
    Rädler PD; Wehde BL; Wagner KU
    Mol Cell Endocrinol; 2017 Aug; 451():31-39. PubMed ID: 28495456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active p21-activated kinase 1 rescues MCF10A breast epithelial cells from undergoing anoikis.
    Menard RE; Jovanovski AP; Mattingly RR
    Neoplasia; 2005 Jul; 7(7):638-45. PubMed ID: 16026643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.
    Li H; Liu Q; Wang Z; Fang R; Shen Y; Cai X; Gao Y; Li Y; Zhang X; Ye L
    J Biol Chem; 2015 Sep; 290(37):22649-61. PubMed ID: 26229107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of HER2/neu overexpression on p53 gene expression, cell proliferation and sensitivity to gamma-irradiation via the PI3K/Akt pathway in breast cancer cell MCF7].
    Zheng L; Ren JQ; Chen Q; Zhang HP; Zhu HG
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):594-7. PubMed ID: 15634518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway.
    Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X
    Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.